Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 2015

View Archived Issues

Endonovo Therapeutics announces new bioelectronic-based platforms for regenerative medicine

Meiji Seika begins two new clinical trials of safinamide for Parkinson's disease

CEVEC and CellGenix establish collaboration and license agreement for CAPGo technology

Horizon Discovery and Servier enter agreement on anticancer kinase inhibitors

Samumed reports DYRK1A inhibitors

Lion Biotechnologies obtains license from NIH to TIL therapy in additional indications

Genocea reports durability data from 6-month analysis of phase II GEN-003 trial

Mixed Hantaan/Puumala virus DNA vaccine shows safety and immunogenicity

Indoximod/ipilimumab combination therapy well tolerated in phase Ib study

Novel multiple ligand trap increases muscle and bone mass

Antibe Therapeutics to move into regenerative medicine through Citagenix acquisition

Lilly's abemaciclib receives FDA breakthrough therapy designation

CMV vaccine elicits humoral and cellular immune responses in animal models

Neurocrine reports data from phase III Kinect 3 study of NBI-98854

Charles River Laboratories announces three discovery collaborations

Bristol-Myers Squibb discloses NS5B inhibitors

Boehringer Ingelheim reports phase II data for BI-655066 in psoriasis

Capella Therapeutics announces EGFR inhibitors

Bayer patents Wnt signaling inhibitors

Prothena presents anti-LAMA4 MAbs

Cell culture-derived influenza vaccine shows excellent immunogenicity

FDA grants 12-year exclusivity to Salix and Pharming's Ruconest

City of Hope receives NIDDK grant to study epigenetic changes in diabetes

ECTRIMS 2015: MEDI-551 is safe in multiple sclerosis patients; phase I results

Altor receives NCI grant to support development of ALT-803 for NHL

Abcam launches anti-PD-L1 antibody research tool

NIH awards grant to Circulomics to advance Nanobind nucleic acid extraction technology

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...